Evaluation of in vitro and in vivo anti-arthritic potential of Berberis calliobotrys

被引:36
作者
Alamgeer [1 ]
Hasan, Umme Habiba [1 ]
Uttra, Ambreen Malik [1 ]
Rasool, Shahid [1 ]
机构
[1] Univ Sargodha, Fac Pharm, Sargodha, Pakistan
关键词
INDUCED ARTHRITIS; MODELS; ASSAY; RATS;
D O I
10.3329/bjp.v10i4.23779
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study was commenced to evaluate the anti-arthritic effect of 70% methanol extract and n-butanol and aqueous fractions of Berberis calliobotrys using both in vitro and in vivo arthritis models. Extract and fractions were investigated in vitro for inhibition of protein (bovine serum and egg albumin) denaturation and human red blood cell membrane stabilization. In vivo antiarthritic activity of extract and fractions at 50, 100 and 200 mg/kg was assessed using turpentine oil and formaldehyde-induced arthritis, while, 200 mg/kg dose was evaluated against complete Freund's adjuvant-induced arthritis. B. calliobotrys produced significant (p<0.001) dose dependent inhibition of protein denaturation and human red blood cell membrane stabilization. In turpentine oil, formaldehyde and complete Freund's adjuvant-induced arthritis models, B. calliobotrys significantly (p<0.001) reduced joint and paw swelling. B. calliobotrys markedly improved body weight, hematology profile, radiological and histopathological parameters in complete Freund's adjuvant model. It could be concluded that B. calliobotrys holds anti-arthritic potential, supporting its traditional use in treatment of rheumatoid arthritis.
引用
收藏
页码:807 / 819
页数:13
相关论文
共 40 条
  • [1] Afuwape AO, 2002, HISTOL HISTOPATHOL, V17, P961, DOI 10.14670/HH-17.961
  • [2] Ahmad I, 2012, INT RES, V1, P169
  • [3] 4-Alkoxybenzamidines as new potent phospholipase A(2) inhibitors
    Aitdafoun, M
    Mounier, C
    Heymans, F
    Binisti, C
    Bon, C
    Godfroid, JJ
    [J]. BIOCHEMICAL PHARMACOLOGY, 1996, 51 (06) : 737 - 742
  • [4] Alamgeer Yuchi Alamgeer Yuchi, 2012, Journal of Medicinal Plants Research, V6, P3222, DOI 10.5897/JMPR12.076
  • [5] THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS
    ARNETT, FC
    EDWORTHY, SM
    BLOCH, DA
    MCSHANE, DJ
    FRIES, JF
    COOPER, NS
    HEALEY, LA
    KAPLAN, SR
    LIANG, MH
    LUTHRA, HS
    MEDSGER, TA
    MITCHELL, DM
    NEUSTADT, DH
    PINALS, RS
    SCHALLER, JG
    SHARP, JT
    WILDER, RL
    HUNDER, GG
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (03): : 315 - 324
  • [6] Chatterjee GK, 1984, IDrugs, V21, P413
  • [7] ALTERATION OF INTERLEUKIN-1 ACTIVITY AND THE ACUTE PHASE RESPONSE IN ADJUVANT ARTHRITIC RATS TREATED WITH DISEASE MODIFYING ANTIRHEUMATIC DRUGS
    CONNOLLY, KM
    STECHER, VJ
    DANIS, E
    PRUDEN, DJ
    LABRIE, T
    [J]. AGENTS AND ACTIONS, 1988, 25 (1-2): : 94 - 105
  • [8] Dhage P., 2013, Int. J. Biol. Pharmaceut. Res., V4, P35
  • [9] PREVENTION OF COLLAGEN-INDUCED ARTHRITIS WITH AN ANTIBODY TO GP39, THE LIGAND FOR CD40
    DURIE, FH
    FAVA, RA
    FOY, TM
    ARUFFO, A
    LEDBETTER, JA
    NOELLE, RJ
    [J]. SCIENCE, 1993, 261 (5126) : 1328 - 1330
  • [10] Eric G, 1996, RHEUMATOID ARTHRITIS, P579